HIV protease inhibitors useful for the treatment of aids
申请人:MERCK & CO. INC.
公开号:EP0534511A1
公开(公告)日:1993-03-31
Compounds of the form,
A-G-J
wherein A is an amine protecting group or urethane, G a dipeptide isostere and J a small terminal group are described. They are distinguished by tetrahydrofuryl or tetrahydropyranyl substituents, and the like. These compounds are useful in the inhibition of HIV protease, the prevention or treatment of infection by HIV and the treatment of AIDS, either as compounds, pharmaceutically acceptable salts, pharmaceutical composition ingredients, whether or not in combination with other antivirals, immunomodulators, antibiotics or vaccines. Methods of treating AIDS and methods of preventing or treating infection by HIV are also described.
HIV protease inhibitors having polyether substituents
申请人:MERCK & CO. INC.
公开号:EP0487270A2
公开(公告)日:1992-05-27
Polyether derivatives of the form,
A-G-B-B-J
wherein G is a dipeptide isostere substituted with a polyether, B an amino acid or analog thereof, and J a small terminal group are described. These compounds are useful in the inhibition of DIV protease, the prevention or treatment of infection by HIV and the treatment of AIDS, either as compounds, pharmaceutically acceptable salts, pharmaceutical composition ingredients, whether or not in combination with other antivirals, immunomodulators, antibiotics or vaccines. Methods of treating AIDS and methods of preventing or treating infection by HIV are also described.
2-Pyrrolidinone derivatives as HIV protease inhibitors
申请人:MERCK & CO. INC.
公开号:EP0550924A1
公开(公告)日:1993-07-14
Compounds of the form,
A-B-G-J
wherein A is an amine protecting group and the like, B an amino acid or analog thereof, wherein G is
and J a small terminal group are described. These compounds are useful in the inhibition of HIV protease, the prevention or treatment of infection by HIV and the treatment of AIDS, either as compounds, pharmaceutically acceptable salts, pharmaceutical composition ingredients, whether or not in combination with other antivirals, immunomodulators, antibiotics or vaccines. Methods of treating AIDS and methods of preventing or treating infection by HIV are also described.